Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 19, Number 3—March 2013

Synopsis

Human Leptospirosis Trends, the Netherlands, 1925–2008

Marga G.A. GorisComments to Author , Kimberly R. Boer, Tamara A.T.E. Duarte, Suzanne J. Kliffen, and Rudy A. Hartskeerl
Author affiliations: Author affiliation: Royal Tropical Institute (KIT), Amsterdam, the Netherlands

Main Article

Table 3

Treatment course and deaths, by infecting Leptospira spp. serogroups, for case-patients with leptospirosis, the Netherlands, 1925–2008*

Serogroup No. patients No. (%) hospitalized No. (%) treated with dialysis No. (%) treated in ICU No (%) died
Icterohaemorrhagiae 1,702 1,311 (77.0) 90 (11.9) 68 (7.0) 90 (5.3)
Grippotyphosa 196 124 (63.3) 3 (2.2) 2 (1.2) 0
Sejroe 128 48 (37.5) 3 (2.4) 2 (1.6) 1 (0.8)
Canicola 93 60 (64.5) 0 0 (0.0) 3 (3.2)
Pomona 54 40 (74.1) 3 (5.6) 7 (13.0) 0
Other 81 55 (67.9) 3 (3.8) 6 (7.6) 1 (1.9)
Unknown 299 213 (71.2) 17 (8.6) 21 (9.3) 71 (23.7)

*ICU, intensive care unit. Data were available for 2,553 patients who were hospitalized or died, 1,360 patients treated with dialysis, and 1,641 patients treated in an ICU.

Main Article

TOP